Forget buy-to-let! I’d buy these 2 FTSE 100 stocks to retire early

I think these two FTSE 100 (INDEXFTSE:UKX) shares could offer improving growth outlooks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The outlook for the buy-to-let industry may be more positive following the general election. Fears surrounding a Jeremy Corbyn-led government and potential changes to taxation may mean that house prices make gains in the short run.

However, in the long run, the FTSE 100 could outperform buy-to-let investments. It appears to offer superior value for money, greater diversity and a range of stocks with sound growth strategies.

With that in mind, here are two FTSE 100 shares that could deliver impressive long-term total returns. They could help to bring your retirement date a step closer.

AstraZeneca

Recent updates from pharma stock AstraZeneca (LSE: AZN) have provided evidence of the scale of its turnaround. While in previous years it has struggled to generate top- and bottom-line growth, its sales and profitability are now growing at double-digit rates. This trend could continue over the medium term as the business benefits from the major investment it has made in its pipeline over recent years.

Risks facing UK investors may have subsided following the recent general election. However, global growth uncertainties remain in place. For example, political risk in the US and China may continue to be high in 2020, while tariffs could act as a drag on global GDP growth. Therefore, AstraZeneca’s defensive characteristics could help it to outperform many of its FTSE 100 peers. Its reduced dependency on the wider economy’s performance may mean that it becomes more popular among investors.

As such, now could be the right time to buy a slice of the company. Its improving financial performance and increasing favour among investors may mean that it outpaces house price growth in the long run.

Bunzl

One FTSE 100 share that is being negatively impacted by an uncertain global macroeconomic outlook is Bunzl (LSE: BNZL). The international distribution and services company recently released a trading update that showed the slowing sales trend from earlier in 2019 has continued.

For example, in its third quarter, the company reported a rise in sales at constant exchange rates of just 0.5%. When the impact of acquisitions is excluded, its sales declined by 1%.

Looking ahead, Bunzl has an active acquisition pipeline. It has already spent £100m on acquisitions this year, and is likely to continue to add new businesses to its portfolio over the medium term. They could catalyse its financial performance and help to offset an uncertain trading period for the business.

With a solid track record of growth that includes five continuous years of increasing earnings, Bunzl could offer long-term growth potential. Following its 12% share price decline in the last year, now could be the right time to buy a slice of it while it trades on a lower valuation. It may fail to recover significantly in the short run, but could offer turnaround potential in the coming years.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

Since December 2023, this FTSE 100 stock’s fallen 32%. Is it now too cheap to overlook?

Our writer explains why he believes this FTSE 100 stock offers tremendous value for money. And considers whether he should…

Read more »

Investing Articles

The easyJet share price has climbed 58% and the dividend is up a stunning 169%!

Harvey Jones is thrilled by the impressive easyJet share price performance this year, and its dividend is flying too. Does…

Read more »

Investing Articles

2 no-brainer FTSE dividend shares I want to buy with £2k

Harvey Jones has identified 2 solid FTSE 100 dividend shares with growth potential. He's aiming to rustle up £2k and…

Read more »

Investing Articles

The BP share price is up 7% in a month but still looks great value with a P/E of 5.73 and 5.67% yield!

Harvey Jones took advantage of this year's dip in the BP share price to load up on the FTSE 100…

Read more »

Investing Articles

£3k in a savings account? It could be earning more passive income elsewhere

While pondering the falling interest rates on savings accounts, our writer considers how a portfolio of reliable stocks could earn…

Read more »

Black father and two young daughters dancing at home
Investing Articles

Just released: our 3 top small-cap stocks to consider buying in December [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Investing Articles

2 precious penny stocks that could offer a golden opportunity!

Like the early gold rush days, penny stocks have a strong allure, offering an opportunity to be a part of…

Read more »

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

4 reasons why I think UK shares will soar in 2025!

As 2024 draws to a close, our writer explains why he’s optimistic that UK shares, including the FTSE 100, will…

Read more »